北京万东医疗科技股份有限公司 第十届监事会第八次会议决议公告

Group 1 - The company held the eighth meeting of the tenth Supervisory Board on May 21, 2025, and approved the adjustment of the 2025 stock option incentive plan, including the list of incentive objects, the number of options granted, and the exercise price [1][3][72] - The meeting was attended by all three supervisors, and the resolutions were passed unanimously [2][4][6] - The company plans to cancel the Supervisory Board and amend the Articles of Association, which will be submitted for shareholder approval [5][7][84] Group 2 - The company announced the resignation of Chairman Hu Ziqiang due to personal reasons, effective immediately, and expressed gratitude for his contributions [10][11] - Ma Chibing was elected as the new Chairman of the Board on May 21, 2025, with a term lasting until the end of the current Board's tenure [12][42] Group 3 - The company will grant 9.6 million stock options to 85 eligible incentive objects, with an exercise price of 15.05 yuan per option, effective from May 21, 2025 [13][14][25] - The initial number of options was adjusted from 10.8 million due to the departure of two incentive objects [76][79] - The stock option incentive plan has undergone necessary approvals and complies with relevant regulations [39][81][82] Group 4 - The company will not set up a Supervisory Board, transferring its responsibilities to the Audit Committee of the Board to enhance governance [84] - The Articles of Association will be revised to reflect this change and other necessary updates [85]